Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
Ovidio de FilippoFrancesco BrunoTineke H PinxterhuisMariusz GąsiorLeor PerlLuca GaidoDomenico TuttolomondoAntonio GrecoRoberto VerardiGianluca Lo MartireMario IannacconeAttilio LeoneGaetano LiccardoSerena CaglioniRocio González FerreiroGiulio RodinòSebastian CinconzeGiuseppe PattiIrene BorzilloFrancesco CardaioliWojciech WańhaBruno CasellaEline H PloumenŁukasz PykaRan KornowskiAndrea GagnorRaffaele PiccoloSergio Raposeiras RoubinDavide CapodannoPaolo ZoccaFederico ConrottoGaetano M De FerrariClemens von BirgelenFabrizio D'Ascenzonull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
Ultrathin-strut DES showed high efficacy and satisfactory safety, even in patients with challenging coronary lesions. Yet, despite using contemporary gold-standard DES, the association persisted between established patient- and procedure-related features of risk and impaired 3-year clinical outcome.